22 03, 2024 Albino Eccher et al., Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing adlitterio663392024-04-10T12:56:50+02:00 Leggi di più
19 03, 2024 Marco Capezzone et al., Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer adlitterio663392024-04-10T12:55:59+02:00 Leggi di più
20 02, 2024 Fabio Canino et al., Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients adlitterio663392024-04-10T14:30:59+02:00 Leggi di più
19 01, 2024 Marcella Barbarino et al., Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA adlitterio663392024-04-10T14:45:32+02:00 Leggi di più
1 01, 2024 Andrea Boscolo Bragadin et al., Integrating clinico-pathological features and longitudinal liquid biopsy results to predict clinical benefit from immune checkpoint Inhibitors in advanced Non-Small Cell Lung Cancer patients adlitterio663392024-04-10T14:43:16+02:00 Leggi di più
23 08, 2023 Maria Raffaella Ambrosio et al., Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study adlitterio663392023-10-17T09:35:51+02:00 Leggi di più
1 08, 2023 Caterina Fumagalli et al., Molecular testing in indeterminate thyroid nodules: an additional tool for clinical decision-making adlitterio663392023-10-17T09:39:38+02:00 Leggi di più
28 07, 2023 Leo Guidobaldi et al., Primary Thyroid Lymphoma: How Molecular Biology and Ancillary Techniques Can Help the Cytopathologist Overcome This Diagnostic Challenge adlitterio663392023-10-17T09:30:36+02:00 Leggi di più
14 07, 2023 Alessandro Pancrazzi et al., BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings adlitterio663392023-10-17T09:23:04+02:00 Leggi di più
16 05, 2023 Daniela Massi et al., Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. adlitterio663392023-10-17T09:13:02+02:00 Leggi di più
